Global Gesagliflozin Supply, Demand and Key Producers, 2026-2032
The global Gesagliflozin market size is expected to reach $ 162 million by 2032, rising at a market growth of 11.9% CAGR during the forecast period (2026-2032).
In 2025, global Garsorasib production reached approximately 5000 units.Garsorasib Tablets (generic name: Garsorasib Tablets, trade name: Anfangning) is an independently developed oral small-molecule targeted antineoplastic drug in China for the treatment of KRAS G12C-mutant advanced non-small cell lung cancer (NSCLC), belonging to irreversible KRAS G12C inhibitors. Its mechanism of action is to specifically bind and lock the inactive conformation of the mutant KRAS protein, block the abnormal activation of the downstream MAPK signaling pathway, thereby inhibiting tumor cell proliferation and inducing tumor cell apoptosis. This product is a 200 mg yellow oval film-coated tablet, approved for marketing in China in November 2024. It is mainly indicated for adult patients with locally advanced or metastatic KRAS G12C-mutant non-small cell lung cancer who have received at least one prior systemic therapy. It serves as an important domestic innovative targeted drug in the field of precision therapy for lung cancer in China.
Garsorasib, as the second KRAS G12C inhibitor approved in China, occupies an important position in the underserved niche market of KRAS G12C-mutant non-small cell lung cancer, relying on the strong commercialization capability of Chia Tai Tianqing. With its inclusion in medical insurance and the successive launch of multiple domestic similar drugs (Fuzolasib, Golorasib, Jilemei), the market has shifted from an early 'blue ocean' to a fiercely competitive stage. Its core advantages lie in domestic innovation, definite efficacy and favorable safety. In addition, price reduction through medical insurance negotiations has rapidly improved patient accessibility. In the future, market competition will focus on price, medical insurance coverage, clinical efficacy, combination therapy, indication expansion (such as colorectal cancer) and commercial channels. Relying on its first-mover advantage, medical insurance coverage and strong channels, Garsorasib is expected to maintain a stable share among similar domestic products, while facing challenges including price wars, medical insurance cost control and intensified competition from rival drugs.
This report studies the global Gesagliflozin production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Gesagliflozin and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gesagliflozin that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Gesagliflozin total production and demand, 2021-2032, (Units)
Global Gesagliflozin total production value, 2021-2032, (USD Million)
Global Gesagliflozin production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Gesagliflozin consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Gesagliflozin domestic production, consumption, key domestic manufacturers and share
Global Gesagliflozin production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Gesagliflozin production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Gesagliflozin production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Gesagliflozin market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include InventisBio, Shanghai Chia Tai Tianqing Pharmaceutical, WuXi AppTec Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gesagliflozin market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Gesagliflozin Market, By Region:
1. How big is the global Gesagliflozin market?
2. What is the demand of the global Gesagliflozin market?
3. What is the year over year growth of the global Gesagliflozin market?
4. What is the production and production value of the global Gesagliflozin market?
5. Who are the key producers in the global Gesagliflozin market?
6. What are the growth factors driving the market demand?
In 2025, global Garsorasib production reached approximately 5000 units.Garsorasib Tablets (generic name: Garsorasib Tablets, trade name: Anfangning) is an independently developed oral small-molecule targeted antineoplastic drug in China for the treatment of KRAS G12C-mutant advanced non-small cell lung cancer (NSCLC), belonging to irreversible KRAS G12C inhibitors. Its mechanism of action is to specifically bind and lock the inactive conformation of the mutant KRAS protein, block the abnormal activation of the downstream MAPK signaling pathway, thereby inhibiting tumor cell proliferation and inducing tumor cell apoptosis. This product is a 200 mg yellow oval film-coated tablet, approved for marketing in China in November 2024. It is mainly indicated for adult patients with locally advanced or metastatic KRAS G12C-mutant non-small cell lung cancer who have received at least one prior systemic therapy. It serves as an important domestic innovative targeted drug in the field of precision therapy for lung cancer in China.
Garsorasib, as the second KRAS G12C inhibitor approved in China, occupies an important position in the underserved niche market of KRAS G12C-mutant non-small cell lung cancer, relying on the strong commercialization capability of Chia Tai Tianqing. With its inclusion in medical insurance and the successive launch of multiple domestic similar drugs (Fuzolasib, Golorasib, Jilemei), the market has shifted from an early 'blue ocean' to a fiercely competitive stage. Its core advantages lie in domestic innovation, definite efficacy and favorable safety. In addition, price reduction through medical insurance negotiations has rapidly improved patient accessibility. In the future, market competition will focus on price, medical insurance coverage, clinical efficacy, combination therapy, indication expansion (such as colorectal cancer) and commercial channels. Relying on its first-mover advantage, medical insurance coverage and strong channels, Garsorasib is expected to maintain a stable share among similar domestic products, while facing challenges including price wars, medical insurance cost control and intensified competition from rival drugs.
This report studies the global Gesagliflozin production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Gesagliflozin and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gesagliflozin that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Gesagliflozin total production and demand, 2021-2032, (Units)
Global Gesagliflozin total production value, 2021-2032, (USD Million)
Global Gesagliflozin production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (Units), (based on production site)
Global Gesagliflozin consumption by region & country, CAGR, 2021-2032 & (Units)
U.S. VS China: Gesagliflozin domestic production, consumption, key domestic manufacturers and share
Global Gesagliflozin production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (Units)
Global Gesagliflozin production by Type, production, value, CAGR, 2021-2032, (USD Million) & (Units)
Global Gesagliflozin production by Application, production, value, CAGR, 2021-2032, (USD Million) & (Units)
This report profiles key players in the global Gesagliflozin market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include InventisBio, Shanghai Chia Tai Tianqing Pharmaceutical, WuXi AppTec Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Gesagliflozin market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Gesagliflozin Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- 100mg
- 200mg
- Garsorasib and Immune Checkpoint Inhibitors
- Garsorasib and FAK Inhibitors
- Innovator
- Generic
- Hospital
- Retail
- Online
- KRAS G12C-Mutant Tumors
- Non-Small Cell Lung Cancer (NSCLC)
- Colorectal Cancer
- Pancreatic Cancer
- Others
- InventisBio
- Shanghai Chia Tai Tianqing Pharmaceutical
- WuXi AppTec Pharmaceutical
1. How big is the global Gesagliflozin market?
2. What is the demand of the global Gesagliflozin market?
3. What is the year over year growth of the global Gesagliflozin market?
4. What is the production and production value of the global Gesagliflozin market?
5. Who are the key producers in the global Gesagliflozin market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Gesagliflozin Introduction
1.2 World Gesagliflozin Supply & Forecast
1.2.1 World Gesagliflozin Production Value (2021 & 2025 & 2032)
1.2.2 World Gesagliflozin Production (2021-2032)
1.2.3 World Gesagliflozin Pricing Trends (2021-2032)
1.3 World Gesagliflozin Production by Region (Based on Production Site)
1.3.1 World Gesagliflozin Production Value by Region (2021-2032)
1.3.2 World Gesagliflozin Production by Region (2021-2032)
1.3.3 World Gesagliflozin Average Price by Region (2021-2032)
1.3.4 North America Gesagliflozin Production (2021-2032)
1.3.5 Europe Gesagliflozin Production (2021-2032)
1.3.6 China Gesagliflozin Production (2021-2032)
1.3.7 Japan Gesagliflozin Production (2021-2032)
1.3.8 India Gesagliflozin Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Gesagliflozin Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Gesagliflozin Major Market Trends
2 DEMAND SUMMARY
2.1 World Gesagliflozin Demand (2021-2032)
2.2 World Gesagliflozin Consumption by Region
2.2.1 World Gesagliflozin Consumption by Region (2021-2026)
2.2.2 World Gesagliflozin Consumption Forecast by Region (2027-2032)
2.3 United States Gesagliflozin Consumption (2021-2032)
2.4 China Gesagliflozin Consumption (2021-2032)
2.5 Europe Gesagliflozin Consumption (2021-2032)
2.6 Japan Gesagliflozin Consumption (2021-2032)
2.7 South Korea Gesagliflozin Consumption (2021-2032)
2.8 ASEAN Gesagliflozin Consumption (2021-2032)
2.9 India Gesagliflozin Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Gesagliflozin Production Value by Manufacturer (2021-2026)
3.2 World Gesagliflozin Production by Manufacturer (2021-2026)
3.3 World Gesagliflozin Average Price by Manufacturer (2021-2026)
3.4 Gesagliflozin Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Gesagliflozin Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Gesagliflozin in 2025
3.5.3 Global Concentration Ratios (CR8) for Gesagliflozin in 2025
3.6 Gesagliflozin Market: Overall Company Footprint Analysis
3.6.1 Gesagliflozin Market: Region Footprint
3.6.2 Gesagliflozin Market: Company Product Type Footprint
3.6.3 Gesagliflozin Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Gesagliflozin Production Value Comparison
4.1.1 United States VS China: Gesagliflozin Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Gesagliflozin Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Gesagliflozin Production Comparison
4.2.1 United States VS China: Gesagliflozin Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Gesagliflozin Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Gesagliflozin Consumption Comparison
4.3.1 United States VS China: Gesagliflozin Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Gesagliflozin Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Gesagliflozin Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Gesagliflozin Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Gesagliflozin Production Value (2021-2026)
4.4.3 United States Based Manufacturers Gesagliflozin Production (2021-2026)
4.5 China Based Gesagliflozin Manufacturers and Market Share
4.5.1 China Based Gesagliflozin Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Gesagliflozin Production Value (2021-2026)
4.5.3 China Based Manufacturers Gesagliflozin Production (2021-2026)
4.6 Rest of World Based Gesagliflozin Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Gesagliflozin Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Gesagliflozin Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Gesagliflozin Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Gesagliflozin Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 100mg
5.2.2 200mg
5.3 Market Segment by Type
5.3.1 World Gesagliflozin Production by Type (2021-2032)
5.3.2 World Gesagliflozin Production Value by Type (2021-2032)
5.3.3 World Gesagliflozin Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY COMBINATION THERAPY
6.1 World Gesagliflozin Market Size Overview by Combination Therapy: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Combination Therapy
6.2.1 Garsorasib and Immune Checkpoint Inhibitors
6.2.2 Garsorasib and FAK Inhibitors
6.3 Market Segment by Combination Therapy
6.3.1 World Gesagliflozin Production by Combination Therapy (2021-2032)
6.3.2 World Gesagliflozin Production Value by Combination Therapy (2021-2032)
6.3.3 World Gesagliflozin Average Price by Combination Therapy (2021-2032)
7 MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
7.1 World Gesagliflozin Market Size Overview by Production Technology: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Production Technology
7.2.1 Innovator
7.2.2 Generic
7.3 Market Segment by Production Technology
7.3.1 World Gesagliflozin Production by Production Technology (2021-2032)
7.3.2 World Gesagliflozin Production Value by Production Technology (2021-2032)
7.3.3 World Gesagliflozin Average Price by Production Technology (2021-2032)
8 MARKET ANALYSIS BY SALES CHANNELS
8.1 World Gesagliflozin Market Size Overview by Sales Channels: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Sales Channels
8.2.1 Hospital
8.2.2 Retail
8.2.3 Online
8.3 Market Segment by Sales Channels
8.3.1 World Gesagliflozin Production by Sales Channels (2021-2032)
8.3.2 World Gesagliflozin Production Value by Sales Channels (2021-2032)
8.3.3 World Gesagliflozin Average Price by Sales Channels (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Gesagliflozin Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 KRAS G12C-Mutant Tumors
9.2.2 Non-Small Cell Lung Cancer (NSCLC)
9.2.3 Colorectal Cancer
9.2.4 Pancreatic Cancer
9.2.5 Others
9.3 Market Segment by Application
9.3.1 World Gesagliflozin Production by Application (2021-2032)
9.3.2 World Gesagliflozin Production Value by Application (2021-2032)
9.3.3 World Gesagliflozin Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 InventisBio
10.1.1 InventisBio Details
10.1.2 InventisBio Major Business
10.1.3 InventisBio Gesagliflozin Product and Services
10.1.4 InventisBio Gesagliflozin Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 InventisBio Recent Developments/Updates
10.1.6 InventisBio Competitive Strengths & Weaknesses
10.2 Shanghai Chia Tai Tianqing Pharmaceutical
10.2.1 Shanghai Chia Tai Tianqing Pharmaceutical Details
10.2.2 Shanghai Chia Tai Tianqing Pharmaceutical Major Business
10.2.3 Shanghai Chia Tai Tianqing Pharmaceutical Gesagliflozin Product and Services
10.2.4 Shanghai Chia Tai Tianqing Pharmaceutical Gesagliflozin Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Shanghai Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
10.2.6 Shanghai Chia Tai Tianqing Pharmaceutical Competitive Strengths & Weaknesses
10.3 WuXi AppTec Pharmaceutical
10.3.1 WuXi AppTec Pharmaceutical Details
10.3.2 WuXi AppTec Pharmaceutical Major Business
10.3.3 WuXi AppTec Pharmaceutical Gesagliflozin Product and Services
10.3.4 WuXi AppTec Pharmaceutical Gesagliflozin Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.3.5 WuXi AppTec Pharmaceutical Recent Developments/Updates
10.3.6 WuXi AppTec Pharmaceutical Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Gesagliflozin Industry Chain
11.2 Gesagliflozin Upstream Analysis
11.2.1 Gesagliflozin Core Raw Materials
11.2.2 Main Manufacturers of Gesagliflozin Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Gesagliflozin Production Mode
11.6 Gesagliflozin Procurement Model
11.7 Gesagliflozin Industry Sales Model and Sales Channels
11.7.1 Gesagliflozin Sales Model
11.7.2 Gesagliflozin Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
1.1 Gesagliflozin Introduction
1.2 World Gesagliflozin Supply & Forecast
1.2.1 World Gesagliflozin Production Value (2021 & 2025 & 2032)
1.2.2 World Gesagliflozin Production (2021-2032)
1.2.3 World Gesagliflozin Pricing Trends (2021-2032)
1.3 World Gesagliflozin Production by Region (Based on Production Site)
1.3.1 World Gesagliflozin Production Value by Region (2021-2032)
1.3.2 World Gesagliflozin Production by Region (2021-2032)
1.3.3 World Gesagliflozin Average Price by Region (2021-2032)
1.3.4 North America Gesagliflozin Production (2021-2032)
1.3.5 Europe Gesagliflozin Production (2021-2032)
1.3.6 China Gesagliflozin Production (2021-2032)
1.3.7 Japan Gesagliflozin Production (2021-2032)
1.3.8 India Gesagliflozin Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Gesagliflozin Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Gesagliflozin Major Market Trends
2 DEMAND SUMMARY
2.1 World Gesagliflozin Demand (2021-2032)
2.2 World Gesagliflozin Consumption by Region
2.2.1 World Gesagliflozin Consumption by Region (2021-2026)
2.2.2 World Gesagliflozin Consumption Forecast by Region (2027-2032)
2.3 United States Gesagliflozin Consumption (2021-2032)
2.4 China Gesagliflozin Consumption (2021-2032)
2.5 Europe Gesagliflozin Consumption (2021-2032)
2.6 Japan Gesagliflozin Consumption (2021-2032)
2.7 South Korea Gesagliflozin Consumption (2021-2032)
2.8 ASEAN Gesagliflozin Consumption (2021-2032)
2.9 India Gesagliflozin Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Gesagliflozin Production Value by Manufacturer (2021-2026)
3.2 World Gesagliflozin Production by Manufacturer (2021-2026)
3.3 World Gesagliflozin Average Price by Manufacturer (2021-2026)
3.4 Gesagliflozin Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Gesagliflozin Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Gesagliflozin in 2025
3.5.3 Global Concentration Ratios (CR8) for Gesagliflozin in 2025
3.6 Gesagliflozin Market: Overall Company Footprint Analysis
3.6.1 Gesagliflozin Market: Region Footprint
3.6.2 Gesagliflozin Market: Company Product Type Footprint
3.6.3 Gesagliflozin Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Gesagliflozin Production Value Comparison
4.1.1 United States VS China: Gesagliflozin Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Gesagliflozin Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Gesagliflozin Production Comparison
4.2.1 United States VS China: Gesagliflozin Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Gesagliflozin Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Gesagliflozin Consumption Comparison
4.3.1 United States VS China: Gesagliflozin Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Gesagliflozin Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Gesagliflozin Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Gesagliflozin Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Gesagliflozin Production Value (2021-2026)
4.4.3 United States Based Manufacturers Gesagliflozin Production (2021-2026)
4.5 China Based Gesagliflozin Manufacturers and Market Share
4.5.1 China Based Gesagliflozin Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Gesagliflozin Production Value (2021-2026)
4.5.3 China Based Manufacturers Gesagliflozin Production (2021-2026)
4.6 Rest of World Based Gesagliflozin Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Gesagliflozin Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Gesagliflozin Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Gesagliflozin Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Gesagliflozin Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 100mg
5.2.2 200mg
5.3 Market Segment by Type
5.3.1 World Gesagliflozin Production by Type (2021-2032)
5.3.2 World Gesagliflozin Production Value by Type (2021-2032)
5.3.3 World Gesagliflozin Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY COMBINATION THERAPY
6.1 World Gesagliflozin Market Size Overview by Combination Therapy: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Combination Therapy
6.2.1 Garsorasib and Immune Checkpoint Inhibitors
6.2.2 Garsorasib and FAK Inhibitors
6.3 Market Segment by Combination Therapy
6.3.1 World Gesagliflozin Production by Combination Therapy (2021-2032)
6.3.2 World Gesagliflozin Production Value by Combination Therapy (2021-2032)
6.3.3 World Gesagliflozin Average Price by Combination Therapy (2021-2032)
7 MARKET ANALYSIS BY PRODUCTION TECHNOLOGY
7.1 World Gesagliflozin Market Size Overview by Production Technology: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Production Technology
7.2.1 Innovator
7.2.2 Generic
7.3 Market Segment by Production Technology
7.3.1 World Gesagliflozin Production by Production Technology (2021-2032)
7.3.2 World Gesagliflozin Production Value by Production Technology (2021-2032)
7.3.3 World Gesagliflozin Average Price by Production Technology (2021-2032)
8 MARKET ANALYSIS BY SALES CHANNELS
8.1 World Gesagliflozin Market Size Overview by Sales Channels: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Sales Channels
8.2.1 Hospital
8.2.2 Retail
8.2.3 Online
8.3 Market Segment by Sales Channels
8.3.1 World Gesagliflozin Production by Sales Channels (2021-2032)
8.3.2 World Gesagliflozin Production Value by Sales Channels (2021-2032)
8.3.3 World Gesagliflozin Average Price by Sales Channels (2021-2032)
9 MARKET ANALYSIS BY APPLICATION
9.1 World Gesagliflozin Market Size Overview by Application: 2021 VS 2025 VS 2032
9.2 Segment Introduction by Application
9.2.1 KRAS G12C-Mutant Tumors
9.2.2 Non-Small Cell Lung Cancer (NSCLC)
9.2.3 Colorectal Cancer
9.2.4 Pancreatic Cancer
9.2.5 Others
9.3 Market Segment by Application
9.3.1 World Gesagliflozin Production by Application (2021-2032)
9.3.2 World Gesagliflozin Production Value by Application (2021-2032)
9.3.3 World Gesagliflozin Average Price by Application (2021-2032)
10 COMPANY PROFILES
10.1 InventisBio
10.1.1 InventisBio Details
10.1.2 InventisBio Major Business
10.1.3 InventisBio Gesagliflozin Product and Services
10.1.4 InventisBio Gesagliflozin Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.1.5 InventisBio Recent Developments/Updates
10.1.6 InventisBio Competitive Strengths & Weaknesses
10.2 Shanghai Chia Tai Tianqing Pharmaceutical
10.2.1 Shanghai Chia Tai Tianqing Pharmaceutical Details
10.2.2 Shanghai Chia Tai Tianqing Pharmaceutical Major Business
10.2.3 Shanghai Chia Tai Tianqing Pharmaceutical Gesagliflozin Product and Services
10.2.4 Shanghai Chia Tai Tianqing Pharmaceutical Gesagliflozin Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.2.5 Shanghai Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
10.2.6 Shanghai Chia Tai Tianqing Pharmaceutical Competitive Strengths & Weaknesses
10.3 WuXi AppTec Pharmaceutical
10.3.1 WuXi AppTec Pharmaceutical Details
10.3.2 WuXi AppTec Pharmaceutical Major Business
10.3.3 WuXi AppTec Pharmaceutical Gesagliflozin Product and Services
10.3.4 WuXi AppTec Pharmaceutical Gesagliflozin Production, Price, Value, Gross Margin and Market Share (2021-2026)
10.3.5 WuXi AppTec Pharmaceutical Recent Developments/Updates
10.3.6 WuXi AppTec Pharmaceutical Competitive Strengths & Weaknesses
11 INDUSTRY CHAIN ANALYSIS
11.1 Gesagliflozin Industry Chain
11.2 Gesagliflozin Upstream Analysis
11.2.1 Gesagliflozin Core Raw Materials
11.2.2 Main Manufacturers of Gesagliflozin Core Raw Materials
11.3 Midstream Analysis
11.4 Downstream Analysis
11.5 Gesagliflozin Production Mode
11.6 Gesagliflozin Procurement Model
11.7 Gesagliflozin Industry Sales Model and Sales Channels
11.7.1 Gesagliflozin Sales Model
11.7.2 Gesagliflozin Typical Distributors
12 RESEARCH FINDINGS AND CONCLUSION
13 APPENDIX
13.1 Methodology
13.2 Research Process and Data Source
13.3 Disclaimer
LIST OF TABLES
Table 1. World Gesagliflozin Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Gesagliflozin Production Value by Region (2021-2026) & (USD Million)
Table 3. World Gesagliflozin Production Value by Region (2027-2032) & (USD Million)
Table 4. World Gesagliflozin Production Value Market Share by Region (2021-2026)
Table 5. World Gesagliflozin Production Value Market Share by Region (2027-2032)
Table 6. World Gesagliflozin Production by Region (2021-2026) & (Units)
Table 7. World Gesagliflozin Production by Region (2027-2032) & (Units)
Table 8. World Gesagliflozin Production Market Share by Region (2021-2026)
Table 9. World Gesagliflozin Production Market Share by Region (2027-2032)
Table 10. World Gesagliflozin Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Gesagliflozin Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Gesagliflozin Major Market Trends
Table 13. World Gesagliflozin Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Gesagliflozin Consumption by Region (2021-2026) & (Units)
Table 15. World Gesagliflozin Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Gesagliflozin Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Gesagliflozin Producers in 2025
Table 18. World Gesagliflozin Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Gesagliflozin Producers in 2025
Table 20. World Gesagliflozin Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Gesagliflozin Company Evaluation Quadrant
Table 22. World Gesagliflozin Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Gesagliflozin Production Site of Key Manufacturer
Table 24. Gesagliflozin Market: Company Product Type Footprint
Table 25. Gesagliflozin Market: Company Product Application Footprint
Table 26. Gesagliflozin Competitive Factors
Table 27. Gesagliflozin New Entrant and Capacity Expansion Plans
Table 28. Gesagliflozin Mergers & Acquisitions Activity
Table 29. United States VS China Gesagliflozin Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Gesagliflozin Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Gesagliflozin Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Gesagliflozin Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Gesagliflozin Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Gesagliflozin Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Gesagliflozin Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Gesagliflozin Production Market Share (2021-2026)
Table 37. China Based Gesagliflozin Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Gesagliflozin Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Gesagliflozin Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Gesagliflozin Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Gesagliflozin Production Market Share (2021-2026)
Table 42. Rest of World Based Gesagliflozin Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Gesagliflozin Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Gesagliflozin Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Gesagliflozin Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Gesagliflozin Production Market Share (2021-2026)
Table 47. World Gesagliflozin Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Gesagliflozin Production by Type (2021-2026) & (Units)
Table 49. World Gesagliflozin Production by Type (2027-2032) & (Units)
Table 50. World Gesagliflozin Production Value by Type (2021-2026) & (USD Million)
Table 51. World Gesagliflozin Production Value by Type (2027-2032) & (USD Million)
Table 52. World Gesagliflozin Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Gesagliflozin Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Gesagliflozin Production Value by Combination Therapy, (USD Million), 2021 & 2025 & 2032
Table 55. World Gesagliflozin Production by Combination Therapy (2021-2026) & (Units)
Table 56. World Gesagliflozin Production by Combination Therapy (2027-2032) & (Units)
Table 57. World Gesagliflozin Production Value by Combination Therapy (2021-2026) & (USD Million)
Table 58. World Gesagliflozin Production Value by Combination Therapy (2027-2032) & (USD Million)
Table 59. World Gesagliflozin Average Price by Combination Therapy (2021-2026) & (US$/Unit)
Table 60. World Gesagliflozin Average Price by Combination Therapy (2027-2032) & (US$/Unit)
Table 61. World Gesagliflozin Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Table 62. World Gesagliflozin Production by Production Technology (2021-2026) & (Units)
Table 63. World Gesagliflozin Production by Production Technology (2027-2032) & (Units)
Table 64. World Gesagliflozin Production Value by Production Technology (2021-2026) & (USD Million)
Table 65. World Gesagliflozin Production Value by Production Technology (2027-2032) & (USD Million)
Table 66. World Gesagliflozin Average Price by Production Technology (2021-2026) & (US$/Unit)
Table 67. World Gesagliflozin Average Price by Production Technology (2027-2032) & (US$/Unit)
Table 68. World Gesagliflozin Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 69. World Gesagliflozin Production by Sales Channels (2021-2026) & (Units)
Table 70. World Gesagliflozin Production by Sales Channels (2027-2032) & (Units)
Table 71. World Gesagliflozin Production Value by Sales Channels (2021-2026) & (USD Million)
Table 72. World Gesagliflozin Production Value by Sales Channels (2027-2032) & (USD Million)
Table 73. World Gesagliflozin Average Price by Sales Channels (2021-2026) & (US$/Unit)
Table 74. World Gesagliflozin Average Price by Sales Channels (2027-2032) & (US$/Unit)
Table 75. World Gesagliflozin Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Gesagliflozin Production by Application (2021-2026) & (Units)
Table 77. World Gesagliflozin Production by Application (2027-2032) & (Units)
Table 78. World Gesagliflozin Production Value by Application (2021-2026) & (USD Million)
Table 79. World Gesagliflozin Production Value by Application (2027-2032) & (USD Million)
Table 80. World Gesagliflozin Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World Gesagliflozin Average Price by Application (2027-2032) & (US$/Unit)
Table 82. InventisBio Basic Information, Manufacturing Base and Competitors
Table 83. InventisBio Major Business
Table 84. InventisBio Gesagliflozin Product and Services
Table 85. InventisBio Gesagliflozin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. InventisBio Recent Developments/Updates
Table 87. InventisBio Competitive Strengths & Weaknesses
Table 88. Shanghai Chia Tai Tianqing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 89. Shanghai Chia Tai Tianqing Pharmaceutical Major Business
Table 90. Shanghai Chia Tai Tianqing Pharmaceutical Gesagliflozin Product and Services
Table 91. Shanghai Chia Tai Tianqing Pharmaceutical Gesagliflozin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Shanghai Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 93. Shanghai Chia Tai Tianqing Pharmaceutical Competitive Strengths & Weaknesses
Table 94. WuXi AppTec Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 95. WuXi AppTec Pharmaceutical Major Business
Table 96. WuXi AppTec Pharmaceutical Gesagliflozin Product and Services
Table 97. WuXi AppTec Pharmaceutical Gesagliflozin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. WuXi AppTec Pharmaceutical Recent Developments/Updates
Table 99. WuXi AppTec Pharmaceutical Competitive Strengths & Weaknesses
Table 100. Global Key Players of Gesagliflozin Upstream (Raw Materials)
Table 101. Global Gesagliflozin Typical Customers
Table 102. Gesagliflozin Typical Distributors
Table 1. World Gesagliflozin Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Gesagliflozin Production Value by Region (2021-2026) & (USD Million)
Table 3. World Gesagliflozin Production Value by Region (2027-2032) & (USD Million)
Table 4. World Gesagliflozin Production Value Market Share by Region (2021-2026)
Table 5. World Gesagliflozin Production Value Market Share by Region (2027-2032)
Table 6. World Gesagliflozin Production by Region (2021-2026) & (Units)
Table 7. World Gesagliflozin Production by Region (2027-2032) & (Units)
Table 8. World Gesagliflozin Production Market Share by Region (2021-2026)
Table 9. World Gesagliflozin Production Market Share by Region (2027-2032)
Table 10. World Gesagliflozin Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Gesagliflozin Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Gesagliflozin Major Market Trends
Table 13. World Gesagliflozin Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (Units)
Table 14. World Gesagliflozin Consumption by Region (2021-2026) & (Units)
Table 15. World Gesagliflozin Consumption Forecast by Region (2027-2032) & (Units)
Table 16. World Gesagliflozin Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Gesagliflozin Producers in 2025
Table 18. World Gesagliflozin Production by Manufacturer (2021-2026) & (Units)
Table 19. Production Market Share of Key Gesagliflozin Producers in 2025
Table 20. World Gesagliflozin Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Gesagliflozin Company Evaluation Quadrant
Table 22. World Gesagliflozin Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Gesagliflozin Production Site of Key Manufacturer
Table 24. Gesagliflozin Market: Company Product Type Footprint
Table 25. Gesagliflozin Market: Company Product Application Footprint
Table 26. Gesagliflozin Competitive Factors
Table 27. Gesagliflozin New Entrant and Capacity Expansion Plans
Table 28. Gesagliflozin Mergers & Acquisitions Activity
Table 29. United States VS China Gesagliflozin Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Gesagliflozin Production Comparison, (2021 & 2025 & 2032) & (Units)
Table 31. United States VS China Gesagliflozin Consumption Comparison, (2021 & 2025 & 2032) & (Units)
Table 32. United States Based Gesagliflozin Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Gesagliflozin Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Gesagliflozin Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Gesagliflozin Production (2021-2026) & (Units)
Table 36. United States Based Manufacturers Gesagliflozin Production Market Share (2021-2026)
Table 37. China Based Gesagliflozin Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Gesagliflozin Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Gesagliflozin Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Gesagliflozin Production, (2021-2026) & (Units)
Table 41. China Based Manufacturers Gesagliflozin Production Market Share (2021-2026)
Table 42. Rest of World Based Gesagliflozin Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Gesagliflozin Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Gesagliflozin Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Gesagliflozin Production, (2021-2026) & (Units)
Table 46. Rest of World Based Manufacturers Gesagliflozin Production Market Share (2021-2026)
Table 47. World Gesagliflozin Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Gesagliflozin Production by Type (2021-2026) & (Units)
Table 49. World Gesagliflozin Production by Type (2027-2032) & (Units)
Table 50. World Gesagliflozin Production Value by Type (2021-2026) & (USD Million)
Table 51. World Gesagliflozin Production Value by Type (2027-2032) & (USD Million)
Table 52. World Gesagliflozin Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Gesagliflozin Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Gesagliflozin Production Value by Combination Therapy, (USD Million), 2021 & 2025 & 2032
Table 55. World Gesagliflozin Production by Combination Therapy (2021-2026) & (Units)
Table 56. World Gesagliflozin Production by Combination Therapy (2027-2032) & (Units)
Table 57. World Gesagliflozin Production Value by Combination Therapy (2021-2026) & (USD Million)
Table 58. World Gesagliflozin Production Value by Combination Therapy (2027-2032) & (USD Million)
Table 59. World Gesagliflozin Average Price by Combination Therapy (2021-2026) & (US$/Unit)
Table 60. World Gesagliflozin Average Price by Combination Therapy (2027-2032) & (US$/Unit)
Table 61. World Gesagliflozin Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Table 62. World Gesagliflozin Production by Production Technology (2021-2026) & (Units)
Table 63. World Gesagliflozin Production by Production Technology (2027-2032) & (Units)
Table 64. World Gesagliflozin Production Value by Production Technology (2021-2026) & (USD Million)
Table 65. World Gesagliflozin Production Value by Production Technology (2027-2032) & (USD Million)
Table 66. World Gesagliflozin Average Price by Production Technology (2021-2026) & (US$/Unit)
Table 67. World Gesagliflozin Average Price by Production Technology (2027-2032) & (US$/Unit)
Table 68. World Gesagliflozin Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Table 69. World Gesagliflozin Production by Sales Channels (2021-2026) & (Units)
Table 70. World Gesagliflozin Production by Sales Channels (2027-2032) & (Units)
Table 71. World Gesagliflozin Production Value by Sales Channels (2021-2026) & (USD Million)
Table 72. World Gesagliflozin Production Value by Sales Channels (2027-2032) & (USD Million)
Table 73. World Gesagliflozin Average Price by Sales Channels (2021-2026) & (US$/Unit)
Table 74. World Gesagliflozin Average Price by Sales Channels (2027-2032) & (US$/Unit)
Table 75. World Gesagliflozin Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 76. World Gesagliflozin Production by Application (2021-2026) & (Units)
Table 77. World Gesagliflozin Production by Application (2027-2032) & (Units)
Table 78. World Gesagliflozin Production Value by Application (2021-2026) & (USD Million)
Table 79. World Gesagliflozin Production Value by Application (2027-2032) & (USD Million)
Table 80. World Gesagliflozin Average Price by Application (2021-2026) & (US$/Unit)
Table 81. World Gesagliflozin Average Price by Application (2027-2032) & (US$/Unit)
Table 82. InventisBio Basic Information, Manufacturing Base and Competitors
Table 83. InventisBio Major Business
Table 84. InventisBio Gesagliflozin Product and Services
Table 85. InventisBio Gesagliflozin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 86. InventisBio Recent Developments/Updates
Table 87. InventisBio Competitive Strengths & Weaknesses
Table 88. Shanghai Chia Tai Tianqing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 89. Shanghai Chia Tai Tianqing Pharmaceutical Major Business
Table 90. Shanghai Chia Tai Tianqing Pharmaceutical Gesagliflozin Product and Services
Table 91. Shanghai Chia Tai Tianqing Pharmaceutical Gesagliflozin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 92. Shanghai Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 93. Shanghai Chia Tai Tianqing Pharmaceutical Competitive Strengths & Weaknesses
Table 94. WuXi AppTec Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 95. WuXi AppTec Pharmaceutical Major Business
Table 96. WuXi AppTec Pharmaceutical Gesagliflozin Product and Services
Table 97. WuXi AppTec Pharmaceutical Gesagliflozin Production (Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 98. WuXi AppTec Pharmaceutical Recent Developments/Updates
Table 99. WuXi AppTec Pharmaceutical Competitive Strengths & Weaknesses
Table 100. Global Key Players of Gesagliflozin Upstream (Raw Materials)
Table 101. Global Gesagliflozin Typical Customers
Table 102. Gesagliflozin Typical Distributors
LIST OF FIGURES
Figure 1. Gesagliflozin Picture
Figure 2. World Gesagliflozin Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Gesagliflozin Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Gesagliflozin Production (2021-2032) & (Units)
Figure 5. World Gesagliflozin Average Price (2021-2032) & (US$/Unit)
Figure 6. World Gesagliflozin Production Value Market Share by Region (2021-2032)
Figure 7. World Gesagliflozin Production Market Share by Region (2021-2032)
Figure 8. North America Gesagliflozin Production (2021-2032) & (Units)
Figure 9. Europe Gesagliflozin Production (2021-2032) & (Units)
Figure 10. China Gesagliflozin Production (2021-2032) & (Units)
Figure 11. Japan Gesagliflozin Production (2021-2032) & (Units)
Figure 12. India Gesagliflozin Production (2021-2032) & (Units)
Figure 13. Gesagliflozin Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Gesagliflozin Consumption (2021-2032) & (Units)
Figure 16. World Gesagliflozin Consumption Market Share by Region (2021-2032)
Figure 17. United States Gesagliflozin Consumption (2021-2032) & (Units)
Figure 18. China Gesagliflozin Consumption (2021-2032) & (Units)
Figure 19. Europe Gesagliflozin Consumption (2021-2032) & (Units)
Figure 20. Japan Gesagliflozin Consumption (2021-2032) & (Units)
Figure 21. South Korea Gesagliflozin Consumption (2021-2032) & (Units)
Figure 22. ASEAN Gesagliflozin Consumption (2021-2032) & (Units)
Figure 23. India Gesagliflozin Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Gesagliflozin by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Gesagliflozin Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Gesagliflozin Markets in 2025
Figure 27. United States VS China: Gesagliflozin Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Gesagliflozin Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Gesagliflozin Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Gesagliflozin Production Market Share 2025
Figure 31. China Based Manufacturers Gesagliflozin Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Gesagliflozin Production Market Share 2025
Figure 33. World Gesagliflozin Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Gesagliflozin Production Value Market Share by Type in 2025
Figure 35. 100mg
Figure 36. 200mg
Figure 37. World Gesagliflozin Production Market Share by Type (2021-2032)
Figure 38. World Gesagliflozin Production Value Market Share by Type (2021-2032)
Figure 39. World Gesagliflozin Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Gesagliflozin Production Value by Combination Therapy, (USD Million), 2021 & 2025 & 2032
Figure 41. World Gesagliflozin Production Value Market Share by Combination Therapy in 2025
Figure 42. Garsorasib and Immune Checkpoint Inhibitors
Figure 43. Garsorasib and FAK Inhibitors
Figure 44. World Gesagliflozin Production Market Share by Combination Therapy (2021-2032)
Figure 45. World Gesagliflozin Production Value Market Share by Combination Therapy (2021-2032)
Figure 46. World Gesagliflozin Average Price by Combination Therapy (2021-2032) & (US$/Unit)
Figure 47. World Gesagliflozin Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Figure 48. World Gesagliflozin Production Value Market Share by Production Technology in 2025
Figure 49. Innovator
Figure 50. Generic
Figure 51. World Gesagliflozin Production Market Share by Production Technology (2021-2032)
Figure 52. World Gesagliflozin Production Value Market Share by Production Technology (2021-2032)
Figure 53. World Gesagliflozin Average Price by Production Technology (2021-2032) & (US$/Unit)
Figure 54. World Gesagliflozin Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 55. World Gesagliflozin Production Value Market Share by Sales Channels in 2025
Figure 56. Hospital
Figure 57. Retail
Figure 58. Online
Figure 59. World Gesagliflozin Production Market Share by Sales Channels (2021-2032)
Figure 60. World Gesagliflozin Production Value Market Share by Sales Channels (2021-2032)
Figure 61. World Gesagliflozin Average Price by Sales Channels (2021-2032) & (US$/Unit)
Figure 62. World Gesagliflozin Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 63. World Gesagliflozin Production Value Market Share by Application in 2025
Figure 64. KRAS G12C-Mutant Tumors
Figure 65. Non-Small Cell Lung Cancer (NSCLC)
Figure 66. Colorectal Cancer
Figure 67. Pancreatic Cancer
Figure 68. Others
Figure 69. World Gesagliflozin Production Market Share by Application (2021-2032)
Figure 70. World Gesagliflozin Production Value Market Share by Application (2021-2032)
Figure 71. World Gesagliflozin Average Price by Application (2021-2032) & (US$/Unit)
Figure 72. Gesagliflozin Industry Chain
Figure 73. Gesagliflozin Procurement Model
Figure 74. Gesagliflozin Sales Model
Figure 75. Gesagliflozin Sales Channels, Direct Sales, and Distribution
Figure 76. Methodology
Figure 77. Research Process and Data Source
Figure 1. Gesagliflozin Picture
Figure 2. World Gesagliflozin Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Gesagliflozin Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Gesagliflozin Production (2021-2032) & (Units)
Figure 5. World Gesagliflozin Average Price (2021-2032) & (US$/Unit)
Figure 6. World Gesagliflozin Production Value Market Share by Region (2021-2032)
Figure 7. World Gesagliflozin Production Market Share by Region (2021-2032)
Figure 8. North America Gesagliflozin Production (2021-2032) & (Units)
Figure 9. Europe Gesagliflozin Production (2021-2032) & (Units)
Figure 10. China Gesagliflozin Production (2021-2032) & (Units)
Figure 11. Japan Gesagliflozin Production (2021-2032) & (Units)
Figure 12. India Gesagliflozin Production (2021-2032) & (Units)
Figure 13. Gesagliflozin Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Gesagliflozin Consumption (2021-2032) & (Units)
Figure 16. World Gesagliflozin Consumption Market Share by Region (2021-2032)
Figure 17. United States Gesagliflozin Consumption (2021-2032) & (Units)
Figure 18. China Gesagliflozin Consumption (2021-2032) & (Units)
Figure 19. Europe Gesagliflozin Consumption (2021-2032) & (Units)
Figure 20. Japan Gesagliflozin Consumption (2021-2032) & (Units)
Figure 21. South Korea Gesagliflozin Consumption (2021-2032) & (Units)
Figure 22. ASEAN Gesagliflozin Consumption (2021-2032) & (Units)
Figure 23. India Gesagliflozin Consumption (2021-2032) & (Units)
Figure 24. Producer Shipments of Gesagliflozin by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Gesagliflozin Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Gesagliflozin Markets in 2025
Figure 27. United States VS China: Gesagliflozin Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Gesagliflozin Production Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Gesagliflozin Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States Based Manufacturers Gesagliflozin Production Market Share 2025
Figure 31. China Based Manufacturers Gesagliflozin Production Market Share 2025
Figure 32. Rest of World Based Manufacturers Gesagliflozin Production Market Share 2025
Figure 33. World Gesagliflozin Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 34. World Gesagliflozin Production Value Market Share by Type in 2025
Figure 35. 100mg
Figure 36. 200mg
Figure 37. World Gesagliflozin Production Market Share by Type (2021-2032)
Figure 38. World Gesagliflozin Production Value Market Share by Type (2021-2032)
Figure 39. World Gesagliflozin Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Gesagliflozin Production Value by Combination Therapy, (USD Million), 2021 & 2025 & 2032
Figure 41. World Gesagliflozin Production Value Market Share by Combination Therapy in 2025
Figure 42. Garsorasib and Immune Checkpoint Inhibitors
Figure 43. Garsorasib and FAK Inhibitors
Figure 44. World Gesagliflozin Production Market Share by Combination Therapy (2021-2032)
Figure 45. World Gesagliflozin Production Value Market Share by Combination Therapy (2021-2032)
Figure 46. World Gesagliflozin Average Price by Combination Therapy (2021-2032) & (US$/Unit)
Figure 47. World Gesagliflozin Production Value by Production Technology, (USD Million), 2021 & 2025 & 2032
Figure 48. World Gesagliflozin Production Value Market Share by Production Technology in 2025
Figure 49. Innovator
Figure 50. Generic
Figure 51. World Gesagliflozin Production Market Share by Production Technology (2021-2032)
Figure 52. World Gesagliflozin Production Value Market Share by Production Technology (2021-2032)
Figure 53. World Gesagliflozin Average Price by Production Technology (2021-2032) & (US$/Unit)
Figure 54. World Gesagliflozin Production Value by Sales Channels, (USD Million), 2021 & 2025 & 2032
Figure 55. World Gesagliflozin Production Value Market Share by Sales Channels in 2025
Figure 56. Hospital
Figure 57. Retail
Figure 58. Online
Figure 59. World Gesagliflozin Production Market Share by Sales Channels (2021-2032)
Figure 60. World Gesagliflozin Production Value Market Share by Sales Channels (2021-2032)
Figure 61. World Gesagliflozin Average Price by Sales Channels (2021-2032) & (US$/Unit)
Figure 62. World Gesagliflozin Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 63. World Gesagliflozin Production Value Market Share by Application in 2025
Figure 64. KRAS G12C-Mutant Tumors
Figure 65. Non-Small Cell Lung Cancer (NSCLC)
Figure 66. Colorectal Cancer
Figure 67. Pancreatic Cancer
Figure 68. Others
Figure 69. World Gesagliflozin Production Market Share by Application (2021-2032)
Figure 70. World Gesagliflozin Production Value Market Share by Application (2021-2032)
Figure 71. World Gesagliflozin Average Price by Application (2021-2032) & (US$/Unit)
Figure 72. Gesagliflozin Industry Chain
Figure 73. Gesagliflozin Procurement Model
Figure 74. Gesagliflozin Sales Model
Figure 75. Gesagliflozin Sales Channels, Direct Sales, and Distribution
Figure 76. Methodology
Figure 77. Research Process and Data Source
